Completed NA INTERVENTIONAL 2-arm NCT01075295

Prevention of Weight Gain in Early Psychoses

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Bipolar I Disorder Bipolar II Disorder Major Depressive Disorder Psychosis Not Otherwise Specified Schizoaffective Disorder Schizophrenia Schizophreniform Disorder Substance-Induced Psychoses

Interventions Behavioural Intervention for the Prevention of Weight Gain TAU

Updated 6 times since 2017 Last updated: Jul 23, 2017 Started: Feb 28, 2010 Primary completion: Dec 31, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01075295, this NA trial focuses on Bipolar I Disorder and Bipolar II Disorder and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 6 times since 2010, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Feb 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
Centre for Addiction and Mental Health

Data source: Centre for Addiction and Mental Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada